Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein

Chemistry and Biology

Volumn 4, Issue 12, 1997, Pages 951-959

  Harper, James D ^a,b   Lieber, Charles M ^c   Lansbury Jr , Peter T ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid; Atomic force microscopy; Nucleation; Protofibril seeding

Indexed keywords

EID: 0031444010     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90303-3     Document Type: Article

References (32)

1. Yankner, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
2. Lansbury, P.T., Jr. (1996). A reductionist view of Alzheimer's disease. Accounts Chem. Res. 29, 317-321.
3. Selkoe, D.J. (1997). Alzheimer's disease: genotypes, phenotype, and treatments. Science 275, 630-631.
4. Lansbury, P.T., Jr. (1997). Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease. Curr. Opin. Chem. Biol. 1, 260-267.
5. Jarrett, J.T., Berger, E.P., & Lansbury, P.T., Jr. (1993). The carboxyl terminus of β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
6. Cai, X.D., Golde, T.E., & Younkin, S.G. (1993). Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
7. Gearing, M., Mori, H., & Mira, S. (1996). Aβ-peptide length and apolipoprotein E genotype in Alzhiemer's disease. Ann. Neurol. 39, 395-399.
8. Harper, J.D., & Lansbury, P.T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385-407.
9. Harper, J.D., Wong, S.S., Lieber, C.M., & Lansbury, P.T., Jr. (1997). Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
10. Bustamante, C., & Keller, D. (1995). Scanning force microscopy in biology. Physics Today 32-38.
11. Dai, H., Hafner, J.H., Rinzler, A.G., Colbert, D.T., & Smalley, R.E. (1996). Nanotubes as nanoprobes in scanning probe microscopy. Nature 384, 147-150.
12. Walsh, D.M., Lomakin, A., Benedek, G.B., Comdron, M.M., & Teplow, D.B. (1997). Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J. Biol. Chem. 272, 22364-22372.
13. Wood, S.J., Chan, W., & Wetzel, R. (1996). An ApoE-Aβ inhibition complex in Aβ fibril extension. Chem. Biol. 3, 949-956.
14. Wood, S.J., Maleeff, B., Hart, T., & Wetzel, R. (1995). Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide A-beta J. Mol. Biol. 256, 870-877.
15. Shen, C.L., & Murphy, R.M. (1995). Solvent effects on self-assembly of β-amyloid peptide. Biophys. J. 69, 640-651.
16. Maggio, J.E., et al., & Mantyh, P.W. (1992). Reversible in vitro growth of Alzheimer's disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc. Natl Acad. Sci. USA 89, 5462-5466.
17. Naiki, H., Higuchi, K., Nakakuki, K., & Takeda, T. (1991). Kinetic analysis of amyloid fibril polymerization in vitro. Lab. Invest. 65, 104-110.
18. Naiki, H., & Nakakuki, K. (1996). First-order kinetic model of Alzheimer's β-amyloid fibril extension in vitro. Lab. Invest. 74, 374-83.
19. Asakura, L. (1970). Polymerization of flagellin and polymorphism of flagella. Adv. Biophys. 1, 99-155.
20. Merz, P.A., Wisniewski, H.M., Somerville, R.A., Bobin, S.A., Masters, C.L., & Iqbal, K. (1983). Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. 60, 113-124.
21. Narang, H.K. (1980). High-resolution electron microscopic analysis of the amyloid fibril in Alzheimer's disease. J. Neuropath. Exp. Neurol. 39, 621-631.
22. Miyakawa, T., Watanabe, K., & Katsuragi, S. (1986). Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 52, 99-106.
23. Roher, A., Wolfe, D., Palutke, M., & KuKuruga, D. (1986). Purification, ultrastructure, and chemical analysis of Alzheimer's disease amyloid plaque core protein. Proc. Natl Acad. Sci. USA 83, 2662-2666.
24. Roher, A.E., Palmer, K.C., Yurewicz, E.C., Ball, M.J., & Greenberg, B.D. (1993). Morphological and biochemical analysis of amyloid plaque core proteins purified from AD brain tissue. J. Neurochem. 61, 1916-1926.
25. Hewlett, D.R., et al., & Roberts, G.W. (1995). Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4, 23-32.
26. Blake, C., & Serpell, L. (1996). Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix. Structure 4, 989-998.
27. Goldsbury, C.S., et al., & Kistler, J. (1997). Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119, 17-27.
28. Bauer, H.H., et al., & Merkle, H.P. (1995). Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Struct. Biol. 115, 1-15.
29. Pollanen, M.S., Markiewicz, P., Weyer, L., Goh, M.C., & Bergeron, C. (1994). Mallory body filaments become insoluble after normal assembly into intermediate filaments. Am. J. Pathol. 145, 1140-1147.
30. Lemere, C.A., Blusztajn, H., Yamaguchi, H., Wisniewski, T., Saido, T.C., & Selkoe, D.J. (1996). Sequence of deposition of heterogeneous amyloid β-peptides and APO E in down syndrome: Implications for initial events in amyloid plaque formation. Neurobiol. Dis. 3, 16-32.
31. Nicoll, J.A.R., Roberts, G.W., & Graham, D.I. (1995). Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1, 135-137.
32. Selkoe, D.J. (1994). Normal and abnormal biology of the beta-amyloid precursor protein. Annu. Rev. Neurosci. 17, 489-517.